Author information from the last article
Articles by Ole A. Andreassen
Ketamine for depression – evidence and proposals for practice
- Tor-Morten Kvam,
- Lowan H. Stewart,
- Andreas Wahl Blomkvist,
- Ole A. Andreassen
25.10.2021:
Current treatment for serious depression is unsatisfactory, and many patients fail to achieve the desired effect. Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine. Although knowledge about adverse effects and the duration of the effect is...
Psychedelic drugs in the treatment of anxiety, depression and addiction
- Tor-Morten Kvam,
- Lowan H. Stewart,
- Ole A. Andreassen
12.11.2018:
In the 1950s and 60s, the classic psychedelic drugs lysergic acid diethylamide (LSD) and psilocybin were tested in numerous clinical trials. The results suggested efficacy against anxiety and depression in cases of life-threatening illness, unipolar depression and addiction (1–3). An open study of...
Diagnosis of dementia – automatic quantification of brain structures
- Knut Engedal,
- Anne Brækhus,
- Ole A. Andreassen,
- Per Hj. Nakstad
21.08.2012:
Dementia has a variety of causes. Alzheimer’s type is the most common (1). Many patients with signs of dementia are not evaluated (2); on the other hand, patients are referred to memory clinics for evaluation at an earlier stage in the development of the disease today than ten years ago (3). They...